EBV LMP2 340-349 Peptide - SSCSSCPLSK

The EBV LMP2 340-349 peptide (SSCSSCPLSK) is a well-characterized epitope derived from latent membrane protein 2 (LMP2) of Epstein-Barr Virus. This sequence has been widely studied for its ability to trigger antigen-specific CD8+ T cell responses, making it a relevant tool for investigating immune control of EBV infection.

LMP2 is expressed during latent infection and plays a role in modulating host cell signaling. As a result, epitopes such as EBV LMP-2 340-349 are frequently used to study immune surveillance mechanisms targeting infected or transformed cells.

The Epstein-Barr Virus (EBV) (strain AG876) Latent membrane protein 2 Peptide (IEDB: 60930) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Latent membrane protein Peptide, H-SSCSSCPLSK-OH (Uniprot: Q1HVJ2 aa: 340-349) from JPT is produced under strict quality control and quality management.

EBV LMP2 340-349 Peptide - SSCSSCPLSK - Specifications

• Peptide sequence: H-SSCSSCPLSK-OH
• Amount: 1 mg
• Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
• Counterion: TFA
• Delivery Format: Freeze-dried in plastic vial
• Application(s): T-cell Immunity
• Condition(s)/Topic(s): Infection
• Standard Delivery Time: approx. 3 weeks

Your Custom or Scrambled Antigen Peptide!

Do you need a scrambled version of this antigen peptide?
We can produce scrambled versions for all our antigen peptides and other peptide sequences. These scrambled peptide versions are cross-checked against the Uniprot database to ensure that the scrambled sequence does not correspond to any natural sequence. Have a look at Scrambled Antigen Peptides!

Are you interested in other antigen peptides?
Choose sequence, amount and purity. We will assist you along the way: Custom Peptide Synthesis

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!